CDH2 and cancer: The aggressive behaviors of cancer cells during the cadherin switching may be explained by the findings that show the interactions between N-cadherin and platelet-derived growth factor receptor (PDGFR) [60] and between N-cadherin and fibroblast growth factor receptor (FGFR).